Cleveland Heights, OH, United States of America

Shalabh Chandra


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shalabh Chandra: Innovator in Cardiac Technology

Introduction

Shalabh Chandra is a notable inventor based in Cleveland Heights, OH (US). He has made significant contributions to the field of cardiac technology, particularly in the area of cardioversion for patients with atrial fibrillation. His innovative approach has the potential to improve patient outcomes in this critical area of healthcare.

Latest Patents

Chandra holds a patent for a "Method and apparatus for predicting the efficacy of cardioversion." This invention involves an apparatus and method designed to predict the success of cardioversion as a modality for reverting a patient with atrial fibrillation to normal sinus rhythm. The process includes measuring blood flow through the patient's atrium, converting and processing this data using nonlinear or chaotic processing to obtain a differential radius signal. The number of excursions of the differential radius beyond a threshold value indicates whether cardioversion will be successful. This innovative method represents a significant advancement in cardiac care.

Career Highlights

Chandra is currently associated with the United States Navy, where he contributes his expertise in developing advanced medical technologies. His work is instrumental in enhancing the effectiveness of cardiac treatments and improving patient care.

Collaborations

Chandra has collaborated with notable colleagues, including Richard A. Katz and Richard A. Grimm. These partnerships have fostered a collaborative environment that encourages innovation and the development of cutting-edge medical solutions.

Conclusion

Shalabh Chandra's contributions to cardiac technology through his patent and work with the United States Navy highlight his commitment to improving healthcare outcomes. His innovative methods in predicting the efficacy of cardioversion are paving the way for advancements in the treatment of atrial fibrillation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…